This site is intended for healthcare professionals

New sub-analysis of the EMPEROR-Reduced phase III trial of Jardiance showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status.- Boehringer + Eli Lilly

Read time: 1 mins
Last updated:26th Oct 2020
Published:24th Oct 2020
Condition: Heart Failure
Type: drug
Register free for full access to